Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo
  1. Home

Novo Nordisk: 80% of Wegovy pill patients are new to weight-loss drugs

  • Posted on May 6, 2026
  • By CNBC
  • 0 Views
  • 1 min read
Novo Nordisk: 80% of Wegovy pill patients are new to weight-loss drugs
Novo Nordisk: 80% of Wegovy pill patients are new to weight-loss drugs

Mike Doustdar, CEO of Novo Nordisk, discusses the company's GLP-1 pill following the release of the company's Q1 earnings.
continue reading...

Author
CNBC

You May Also Like